Home › Burkitt Lymphoma › Tennessee › Memphis
Burkitt Lymphoma clinical trials in Memphis, TN
3 studies for Burkitt Lymphoma are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RecruitingPhase 2
- Saint Jude Children's Research Hospital, Memphis
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
RecruitingPhase 1
- St. Jude Children's Research Hospital, Memphis
CAR T-cell Long-Term Follow-Up, Quality of Life and Adverse Reactions
RecruitingObservational study
- St. Jude Children's Research Hospital, Memphis
Burkitt Lymphoma trials in other cities
- Houston, TX21 studies
- Milwaukee, WI16 studies
- Philadelphia, PA16 studies
- New York City, NY14 studies
- Chicago, IL13 studies
- Cincinnati, OH12 studies
- Seattle, WA12 studies
- Atlanta, GA11 studies
- Boston, MA10 studies
- Los Angeles, CA10 studies
- Durham, NC10 studies
- Aurora, CO10 studies
Other studies in Memphis
- Cancer (all types)31 studies
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer21 studies
- Sickle Cell Disease18 studies
- Lung Cancer18 studies
- Acute Lymphoblastic Leukemia16 studies
- Acute Myeloid Leukemia15 studies
- Heart Failure13 studies
- Colorectal Cancer11 studies
- Prostate Cancer11 studies
- Melanoma11 studies
- Soft Tissue Sarcoma11 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.